MétaCan
Menu
← Back to cohort
Record W4403832879 · doi:10.1681/asn.2024e0s64gv6

Advancing Community Care and Access to Follow-Up after AKI Hospitalization: The AFTER AKI Randomized Controlled Trial

2024· article· en· W4403832879 on OpenAlexaffabout
Neesh Pannu, Kerry McBrien, Coralea Bignell, Eleanor Benterud, Taylor Palechuk, Tyrone G. Harrison, Braden Manns, Matthew T. James

Bibliographic record

VenueJournal of the American Society of Nephrology · 2024
Typearticle
Languageen
FieldMedicine
TopicOrgan Donation and Transplantation
Canadian institutionsUniversity of CalgaryUniversity of Alberta
Fundersnot available
KeywordsRandomized controlled trialMedicineIntensive care medicineAcute kidney injuryEmergency medicineInternal medicine

Abstract

fetched live from OpenAlex

Background: Acute kidney injury (AKI) is associated with development and progression of chronic kidney disease (CKD). Gaps in guideline recommended care for CKD are common after AKI. Methods: In this randomized controlled trial conducted in Alberta, Canada, hospitalized adults with Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or greater AKI were randomized to a risk-guided, transition of care intervention versus usual discharge practices at hospital discharge. For people in the intervention group, we used a validated risk index to predict risk of severe CKD after AKI to risk stratify patients. People at low risk (<1%) received patient education alone. People at medium risk received additional clinical guidance, provided to their primary care physician. People at high risk (>10%) were referred to Nephrology. The primary outcome was the proportion of patients with CKD who were receiving guideline-concordant care at 90 days after discharge based on use of ACE inhibitors or ARBs, statins, and nephrology specialist follow-up. Processes of care and safety were also evaulated. Results: We recruited 155 patients into the trial; mean (SD) age 60 (15) years, 91 (60%) were male. 90 days after discharge, 99 (64%) participants had CKD defined by estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2 or albumin to creatinine ratio (ACR) >30 mg/g. The proportion of participants with CKD after hospitalization with AKI who received guideline-concordant care was 59% in the intervention group versus 24% in the usual-care group (absolute risk difference [RD] 35 %, 95% CI, 17 to 53%; P < 0.001; risk ratio 2.47, 95% CI, 1.43 to 4.25). ACE inhibitor or ARB use was higher with the intervention (67 versus 46%, RD 21%, 95% CI, 2-40] %), as was statin use (78 versus 58%, RD 20%, 95% CI, 2 to 38 %). Among 18 (12%) participants with eGFR <30 mL/min/1.73m2 at 90 days, the proportion who received nephrology follow-up was also greater with the intervention (73 versus 29%, RD 44, 95% CI, 2 to 87%). The risk of adverse events was similar in the groups, except for hyperkalemia, which was more frequent in the intervention group (15% versus 5%). Conclusion: A risk-guided intervention for patients with AKI increased CKD-guideline concordant care early after hospital discharge. Funding: Government Support - Non-U.S.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0000.001
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0060.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.300
Teacher spread0.291 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the American Society of Nephrology→Same topicOrgan Donation and Transplantation→French-language works237,207→